JVJurica Vuković

Jurica Vuković

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jurica Vuković has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cystic fibrosis – new therapeutic aproaches

    by Duška Tješić-Drinković, Lana Omerza, Ivan Bambir, Ivana Todorić, Mirna Natalija Aničić, Irena Senečić-Čala, Jurica Vuković, Andrea Vukić Dugac, Dorian Tješić-Drinković

    Uvod: Mongenska autosomno recesivno nasljedna bolest cistična fibroza (CF) prije pedesetak je godina završavala smrću u ranom djetinjstvu. Devedesetih se godina, zahvaljujući simptomatskom liječenju uz strukturiran, sveobuhvatan multidisciplinarni pr...

  • Open Access

    252 Evaluation of Changes in Nutritional Status in Re-Hospitalized Children

    by Gabriela Živković, Lana Omerza, Mirna Natalija Aničić, Irena Senečić-Čala, Jurica Vuković, Duška Tješić-Drinković

    This is a one-year follow-up study looking into the nutritional status and the rate of re-hospitalizations in children at the UHC Zagreb, Dept. of Paediatrics who were first evaluated during the nutritionDay (nDay) in November 2018. The aim is to evaluate the accuracy of STRONGkids questionnaires, subjective assessment within nDay survey and anthropometry in detecting malnutrition and possible relation to number of hospital admissions and disease outcomes (for oncology patients) within a year. The study included 50 patients (mean age 13.48 years ±3.79, 22 males) whose nutritional status was estimated in November 2018. Additional data were collected after the period of 12 months. Mann-Whitney U, Kruskal Wallis and Wilcoxon signed-ranks tests were applied. A significantly different BMI was found among subgroups categorized through the nDay survey (without risk, at risk, malnourished patients) and among subgroups assessed by STRONGkids (low, medium and high risk for malnutrition) (p1=0.002, p2=0.003, resp.). Post hoc tests showed that statistical significance could be contributed to differences between groups malnourished patients vs. those not at risk within nDay (p3=0.009) and between groups low vs. high and medium vs. high risk defined through STRONGkids questionnaires (p4=0.020, p5=0.004, resp.). In the one-year follow-up period, 28/50 children were re-hospitalized once or several times. The number of re-hospitalizations was significantly higher for children classified by STRONGkids to have high risk for malnutrition (p6=0.002), as well as for those categorized as malnourished through the nDay survey (p7=0.024). No significant difference in z-score BMI values was found between years 2018 and 2019 (Wilcoxon signed-rank test: p8=0.086). Re-hospitalized oncology patients (11) were additionally analysed in respect of their disease status: favourable outcome (disease regression; 8/11) vs. unfavourable outcome (progression or unchanged state; 3/11). No difference was observed in the initial BMI between these groups (Mann-Whitney U test: p9=0.921), and no significant change in their BMI during this period was observed in either group (Wilcoxon signed-rank test: p10=0.161, p11=0.593). Patients categorized as malnourished both with STRONGkids and nDay survey had significantly lower BMI than the rest of subjects. Our data support the hypothesis that malnourished patients have a higher rate of re-hospitalizations. Within the observational period, re-hospitalized patients neither improved nor worsened their nutritional status according to the BMI z-scores. We were not able to connect the nutritional status of oncology patients with their disease outcome after one year, perhaps due to a rather small sample or short time of follow-up.

  • Open Access

    282 Gastroscopy in pediatrics – 4 year experience

    by Nedo Marčinković, Matea Kovačić, Jurica Vuković, Duška Tješić Drinković, Irena Senečić-Čala, Lana Omerza, Mirna Natalija Aničić

    Objective Comparing the referral diagnosis as an indication for EGD with final histological diagnosis, and to assess whether it was justified to perform these endoscopies in our patients. Methods Retrospective analysis of patients who underwent gastroscopy with biopsy in the period from 1.1.2016. to 29.02.2020 at the Clinical Hospital Center Zagreb. The study did not include foreign body removal procedures, follow up endoscopies and endoscopies for the purpose of placing medical orthopedic aids. We have described the symptoms leading to referral for endoscopy, as well as their average duration prior to endoscopy. We analyzed the correlation between referral and final histological diagnosis. Results In a cohort of a total of 100 patients, the most common indication for gastroscopy in 24/100 (24%) was abdominal pain, and in approximately half of them (13/24, 54.2%) the histological cause of the discomfort was found (gastritis in 12 and celiac disease in 1). Of the 20 gastroscopies performed on suspicion of gastritis, in 12/20 (60%) pathological substrate was found (9 gastritis, 2 eosinophilic esophagitis, 1 celiac disease). Due to celiac disease suspicion, we endoscopied 18 patients, of whom in 10 (55.6%) celiac disease was histologically confirmed. In 6/11 (54.5%) patients with dyspeptic symptoms diagnosis of gastritis was made after the endoscopy. In almost half of the patients, the pathohistological finding was normal. From 52 pathological findings; 31/52 (59.6%) corresponds to gastritis, 12/52 (23.1%) to celiac disease, 5/52 (9.6%) to eosinophilic esophagitis, and in 2 patients (3.8%) esophageal varices and stomach polyps were found. The average duration of discomfort was 10 months and 26 days, while the largest number of patients; 17 of them had symptoms for a year, 16 had problems for 6 months, 9 had symptoms for 2 years, and 8 had symptoms for 1 and 3 months, respectively before the endoscopy. It should be noted that 10 were asymptomatic and were referred for endoscopy on the basis of pathological laboratory findings (complete blood count, iron, antibodies to tissue transglutaminase) or specific anamnesis (body weight loss, failure to thrive). Endoscopy completion rate by entering into the distal end of duodenum was 100%. We did not record any complications. Conclusion Considering the nonspecific symptoms of the disease that greatly correlate with functional difficulties the number of negative findings is not surprising. But since gastroscopy is the most sensitive method of confirmation/exclusion of the disease itself it is clear that a high number of negative findings point to the necessity of developing clearer guidelines to avoid unnecessary endoscopies. Furthermore, comparing our results with the results of similar foreign studies we can say that we are within the world average and that this indeed is a global problem that requires team effort especially at a time when the number of endoscopic procedures grows rapidly every day due to increased endoscopic possibilities.

  • Open Access

    241 Acute liver failure in newly diagnosed Wilson’s disease – recovery without transplantation

    by Mario Mašić, Ivana Trivić, Ana Močić Pavić, Iva Hojsak, Sanja Kolaček, Zrinjka Mišak, Alenka Gagro, Ivančica Škarić, Tonći Grmoja, Martin Ćuk, et al.

    Wilson’s disease (WD) is an autosomal recessive genetic disorder that leads to the impairment of cellular copper metabolism. Clinical presentation is heterogeneous, with predominantly hepatic, neurological and psychiatric manifestations. Acute decompensated WD presenting as fulminant liver failure is a life-threatening condition for which liver transplantation is the ultimate treatment. 14-year-old girl presented with acute abdominal pain and peripheral oedema lasting two weeks before onset of abdominal pain. On initial examination, patient was febrile, complaining of periumbilical pain, dyspnea, cough, presenting with anasarca, extensive limb oedema and ascites (gained 17 kg), without encephalopathy. Laboratory evaluation revealed Coombs-negative haemolytic anaemia (Hb 101 g/L, Rtc 125x109/L), thrombocytopenia (79x109/L), leukocytosis (19.27x109/L), mildly elevated inflammatory markers, hypergammaglobulinemia (IgG 21.7g/L) with reduced complement components (C3 0.24g/L, C42.5), marked hypoalbuminemia (>15 g/L), mildly elevated bilirubin (49 µmol/L), slightly elevated liver enzymes (AST 63 U/L, GGT 98 U/L), borderline serum ammonia (52.3 µmol/L), normal ALT and alkaline phosphatase. Abdominal ultrasound showed large amounts of ascites, with mildly enlarged, structurally altered liver (irregular surface, nodular parenchyma) and splenomegaly, with no signs of hepatic vein thrombosis on Color Doppler and MRI. Heart ultrasound was normal. Kayser-Fleischer ring was negative on slit lamp examination. Viral serology (HAV, HBV, HCV, HEV, EBV, CMV, and Parvo B19) was negative as well as autoantibodies (ANA, SMA, LKM, ANCA, anti dsDNA). Serum alpha-1 antitrypsin level was normal. Diagnosis of Wilson’s disease was practically confirmed after demonstrating pronounced cupriuria (17.8 µmol/24h); serum ceruloplasmin was low (0.13 g/L) and serum copper levels slightly reduced (10.1 umol/L). Initial treatment was supportive (albumin infusions, vitamin K, fresh frozen plasma, diuretics, lactulose, antibiotics). Liver transplant was considered (on admission MELD score 24, King’s Wilson index 12; on day 10 MELD score 18, King’s Wilson index 8). The decision was made to attempt plasma exchange over three days and introduce penicillamine. The patient improved clinically, tolerated penicillamine well and was released subsequently after 34 days of hospitalization and five plasma exchanges overall. Liver synthetic function completely normalized few months later. Genetic analysis of ATP7B gene (H1069Q mutation) confirmed presence of the H1069Q mutation on one allele. We presented a patient suffering from WD in whom the disease presented acutely with development of liver failure with near-normal values of liver enzymes, mild hyperbilirubinemia, markedly impaired synthetic liver function and Coombs-negative haemolytic anaemia. Acute liver failure in WD may be successfully managed with plasma exchange therapy.

  • Pulse Wave Velocity as a Method of Outcome Monitoring after Renal Denervation

    by Iva Kurjaković, Juraj Jug, Martina Lovrić Benčić, Jurica Vuković, Ingrid Prkačin

  • Oscillometric Measurement of Pulse Wave Velocity in Hypertensive Crisis

    by Lucija Bilinovac, Iva Kurjaković, Jurica Vuković, Juraj Jug, Martina Lovrić-Benčić, Ingrid Prkačin